1. Associations Between Brainstem Volume and Alzheimer's Disease Pathology in Middle-Aged Individuals of the Framingham Heart Study.
- Author
-
Jacobs, Heidi IL, O'Donnell, Adrienne, Satizabal, Claudia L, Lois, Cristina, Kojis, Daniel, Hanseeuw, Bernard J, Thibault, Emma, Sanchez, Justin S, Buckley, Rachel F, Yang, Qiong, DeCarli, Charles, Killiany, Ron, Sargurupremraj, Muralidharan, Sperling, Reisa A, Johnson, Keith A, Beiser, Alexa S, and Seshadri, Sudha
- Subjects
Biomedical and Clinical Sciences ,Biological Psychology ,Clinical Sciences ,Neurosciences ,Psychology ,Dementia ,Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) ,Brain Disorders ,Aging ,Alzheimer's Disease ,Neurodegenerative ,Acquired Cognitive Impairment ,Biomedical Imaging ,2.1 Biological and endogenous factors ,Aetiology ,Neurological ,Alzheimer Disease ,Amyloid beta-Peptides ,Brain Stem ,Humans ,Longitudinal Studies ,Middle Aged ,tau Proteins ,amyloid ,brainstem ,tau ,Cognitive Sciences ,Neurology & Neurosurgery ,Clinical sciences ,Biological psychology - Abstract
The brainstem is among the first regions to accumulate Alzheimer's disease (AD)-related hyperphosphorylated tau pathology during aging. We aimed to examine associations between brainstem volume and neocortical amyloid-β or tau pathology in 271 middle-aged clinically normal individuals of the Framingham Heart Study who underwent MRI and PET imaging. Lower volume of the medulla, pons, or midbrain was associated with greater neocortical amyloid burden. No associations were detected between brainstem volumes and tau deposition. Our results support the hypothesis that lower brainstem volumes are associated with initial AD-related processes and may signal preclinical AD pathology.
- Published
- 2022